Press

Christina had the pleasure to discuss on OncTimes Talk the reasons behind leukemia cells’ resistance to BH3 mimetics. The podcast can be found here.

Our recent Cancer Discovery study findings were discussed in an article in Oncology Times Kumar Das, Dibash, Oncology Times 45(S16):1,3, August 20, 2023., doi: 10.1097/01.COT.0000967188.44089.c8

In the news today! Rutgers Cancer Institute Researcher Awarded V Foundation for Cancer Research Grant

Christina discusses our recent research findings in Oncology Tube Video here Christina Glytsou, PhD, shows that a drug combination can restore the signaling ability of a leading treatment for blood … Read More

Our recent study is featured in the Cancer Institute of New Jersey news Study Explores Potential Therapeutic Approach to Acute Myeloid Leukemia Acute myeloid leukemia (AML) is the most common … Read More